Sanofi settles with US HHS over allegations related to patient assistance

The US subsidiary of French pharma major Sanofi (Euronext: SAN) says it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation relating to certain financial donations made in 2015 and 2016 to an independent charity patient assistance foundation that aided patients living with multiple sclerosis.

As part of the settlement, Sanofi US has also entered into a Corporate Integrity Agreement (CIA) with the Office of the Inspector General of the US Department of Health and Human Services. Many of the requirements are already incorporated into the company's existing US compliance program. Sanofi is committed to compliance, and the Company's compliance program is regularly enhanced to ensure its controls meet or exceed the complex and evolving legal, regulatory, and industry requirements, as well as the expectations of patients and providers.

This resolution reflects the company's desire to put this investigation behind it and to continue its focus on the needs of patients. It does not constitute any admission of guilt.